At a glance
- Originator Indevus Pharmaceuticals
- Class Hypnosedatives; Sleep disorder therapies; Small molecules; Tryptamines
- Mechanism of Action Melatonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Insomnia
Most Recent Events
- 08 Jun 2001 Discontinued-Preclinical for Insomnia in USA (PO)
- 15 Jan 1999 Suspended-Preclinical for Insomnia in USA (PO)
- 20 Feb 1997 Preclinical development for Insomnia in USA (PO)